Pure and Applied Chemistry, 2000, Volume 72, No. 3, pp. 347-354, Cited by

Pure Appl. Chem., 2000, Vol. 72, No. 3, pp. 347-354

http://dx.doi.org/10.1351/pac200072030347

Novel reagents and reactions for drug design

T. J. Baker, Y. Rew and M. Goodman*

Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0343, USA

Bojnik Engin, Babos Fruzsina, Fischetti Carmela, Magyar Anna, Camarda Valeria, Borsodi Anna, Bajusz Sándor, Calo’ Girolamo, Benyhe Sándor: Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. Brain Research Bull 2010, 81, 477. <http://dx.doi.org/10.1016/j.brainresbull.2009.09.013>
Jiao Guan-Sheng, Cregar Lynne, Goldman Mark E., Millis Sherri Z., Tang Cho: Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors. Bioorganic & Medicinal Chemistry Letters 2006, 16, 1527. <http://dx.doi.org/10.1016/j.bmcl.2005.12.038>
Jiao Guan-Sheng, Simo Ondrej, Nagata Melissa, O’Malley Sean, Hemscheidt Thomas, Cregar Lynne, Millis Sherri Z., Goldman Mark E., Tang Cho: Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease. Biorg Med Chem Lett 2006, 16, 5183. <http://dx.doi.org/10.1016/j.bmcl.2006.07.005>
Goodman Murray, Zapf Christoph, Rew Yosup: New reagents, reactions, and peptidomimetics for drug design. Biopolymers (Biospectroscopy) 2001, 60, 229. <http://dx.doi.org/10.1002/1097-0282(2001)60:3<229::AID-BIP10034>3.0.CO;2-P>